Crystal structure of apixaban-bound racemic ABLE
Zhao, K., Li, T.To be published.
Experimental Data Snapshot
Starting Model: experimental
View more details
Entity ID: 1 | |||||
---|---|---|---|---|---|
Molecule | Chains | Sequence Length | Organism | Details | Image |
D-ABLE | 126 | synthetic construct | Mutation(s): 0  | ||
Sequence AnnotationsExpand | |||||
|
Entity ID: 2 | |||||
---|---|---|---|---|---|
Molecule | Chains | Sequence Length | Organism | Details | Image |
L-ABLE | 126 | synthetic construct | Mutation(s): 0  | ||
Entity Groups   | |||||
Sequence Clusters | 30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity | ||||
Sequence AnnotationsExpand | |||||
|
Ligands 1 Unique | |||||
---|---|---|---|---|---|
ID | Chains | Name / Formula / InChI Key | 2D Diagram | 3D Interactions | |
GG2 (Subject of Investigation/LOI) Query on GG2 | C [auth A], D [auth B] | 1-(4-METHOXYPHENYL)-7-OXO-6-[4-(2-OXOPIPERIDIN-1-YL)PHENYL]-4,5,6,7-TETRAHYDRO-1H-PYRAZOLO[3,4-C]PYRIDINE-3-CARBOXAMIDE C25 H25 N5 O4 QNZCBYKSOIHPEH-UHFFFAOYSA-N |
Length ( Å ) | Angle ( ˚ ) |
---|---|
a = 33.362 | α = 90.53 |
b = 42.483 | β = 97.91 |
c = 43.994 | γ = 110.83 |
Software Name | Purpose |
---|---|
PHENIX | refinement |
CrysalisPro | data reduction |
PHASER | phasing |
CrysalisPro | data scaling |
Funding Organization | Location | Grant Number |
---|---|---|
Other private | China | 32120103013 |
Other government | China | No. 2021C03040 |
National Natural Science Foundation of China (NSFC) | China | 22077104 |